588 completed, 155 unknown, 104 recruiting, 49 not yet recruiting. 273 Phase 1, 207 Phase 2, 202 Phase 3, 186 Phase 4, 143 Not applicable.
Follow Tablets: new trials by email Literature Review of Tablets trials Research Report on Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN Tetramethylpyrazine nitrone (TBN) tablet / Placebo - Healthy | Phase 1 | Not yet recruiting | Guangzhou Magpie Pharmaceuticals Co., Ltd. | 16 | 2028-09-01 | 2026-09-11 |
| Oral Fosamprenavir for GERD Fosamprenavir Calcium 700 MG Oral Tablet, Placebo - Refractory Gastroesophageal Reflux Disease, Gastroesophageal Reflux Disease | Phase 2 | Not yet recruiting | Medical College of Wisconsin | 60 | 2027-10-01 | 2026-09-10 |
| A Multicenter Safety and Immunogenicity Window-of-opportunity Phase 1 Interventional Trial Assessing the Combination of IDH1 Vaccine (IDH1-vac) and Vorasidenib in Adult Patients With Recurrent IDH1R132H-mutant Astrocytoma, Grade 2 - 4 (iVOCAL) IDH1R132H-vac, Vorasidenib 40 mg Oral Tablet, Aldara - Imiquimod 5% - Recurrent IDH1R132H-mutant Astrocytoma, Grade 2 - 4 | Phase 1 | Not yet recruiting | Heidelberg University | 45 | 2027-01-01 | 2026-10-16 |
| HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation ivermectin infant formula preparation, Standard ivermectin 3mg tablet - Scabies | Phase 1 | Suspended | Murdoch Childrens Research Institute | 52 | 2027-01-01 | 2026-10-09 |
| Validation & Intervention Testing for Aging, Longevity and Healthspan Dapagliflozin 10Mg Oral Tablet, Semaglutide oral, Placebo - Aging, Functional Decline | Phase 2 | Not yet recruiting | The University of Texas Health Science Center at San Antonio | 1200 | 2027-01-01 | 2026-11-06 |
| This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcting Early-onset Vitamin B12 Deficiency in Adult Patients Using Proton Pump Inhibitors (PPIs). The Primary Outcome is the Change in Serum Vitamin B12 Levels Over a 6-week Cyanocobalamin 1000 Mcg Oral Tablet, Cyanocobalamin 1000 Mcg Sublingual Tablet, Proton Pump Inhibitor therapy only - Hypovitaminosis b 12 | Phase 3 | Not yet recruiting | Tanta University | 23 | 2026-12-30 | 2025-05-13 |
| Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic Hyperplasia Finasteride 5 mg Tablet, single dose, Tamsulosin 0.4Mg Capsule - Benign Prostatic Hyperplasia | Phase 3 | Not yet recruiting | Il-Yang Pharm. Co., Ltd. | 660 | 2026-11-09 | 2026-10-13 |
| Netupitant/Palonosetron for Prevention of Nausea and Vomiting in Breast Cancer ADC Therapy Netupitant and Palonosetron, Dexamethasone, Olanzapine 5 Mg ORAL TABLET - Breast Cancer | Phase 2 | Not yet recruiting | Fudan University | 84 | 2026-11-02 | 2026-11-05 |
| Pentoxifylline Add-On Therapy for Mild-to-Moderate Plaque Psoriasis Pentoxifylline 400 mg Oral Tablet, Placebo - Psoriasis | Not applicable | Not yet recruiting | Wasuchon Chaichan | 140 | 2026-11-01 | 2026-10-06 |
| T4/T3 Therapy in Hypothyroidism Liothyronine (L-T3), Levothyroxine Sodium (LT4) Tablets, Liothyronine (LT3) placebo - Hypothyroidism Primary | Phase 2 | Not yet recruiting | University of Pennsylvania | 60 | 2026-11-01 | 2026-08-20 |
| Colchicine in Pulmonary Artery Hypertension Patients Colchicine 0.5 MG Oral Tablet - Pulmonary Hypertension | Phase 2 | Not yet recruiting | Ain Shams University | 60 | 2026-10-31 | 2026-10-30 |
| Colchicine Effect on Amyotrophic Lateral Sclerosis Patients Colchicine 0.5 MG Oral Tablet, Placebo Oral Tablet - Amyotrophic Lateral Sclerosis | Phase 2 | Not yet recruiting | Azienda Ospedaliero-Universitaria di Modena | 87 | 2026-10-01 | 2026-09-10 |
| Study of CDK8 Inhibitor RVU120 in Combination With Everolimus in Children With Recurrent or Progressive Group 3 or 4 Medulloblastoma RVU120, Everolimus (Afinitor) tablets - Medulloblastoma Recurrent, Medulloblastoma | Phase 1 | Not yet recruiting | Bożenna Dembowska Bagińska | 48 | 2026-09-01 | 2026-10-08 |
| Bempedoic Acid Therapy for Polycystic Kidney Disease Bempedoic Acid 180 MG Oral Tablet, Placebo Capsule(s) - ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Phase 2 | Recruiting | Kenneth Hallows | 120 | 2026-09-01 | 2026-09-29 |
| Pirfenidone as Treatment of Chronic Pancreatitis Pirfenidone 267 mg Oral Tablet, Placebo, PROMIS-Global Health - Chronic Pancreatitis | Phase 2 | Not yet recruiting | Vikas Dudeja | 60 | 2026-08-01 | 2026-08-10 |
| A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard Treatment Avatrombopag 20 mg Oral Tablet - Aplastic Anemia | Phase 2 / Phase 3 | Not yet recruiting | Swedish Orphan Biovitrum | 26 | 2026-07-31 | 2026-08-26 |
| An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease Placebo, Atomoxetine, Metformin 1000 mg Oral Tablet - Alzheimer's Disease (AD), Mild Cognitive Impairment Due to Alzheimer's Disease | Phase 3 | Recruiting | University College, London | 1200 | 2026-07-24 | 2026-07-23 |
| SGLT2i Therapy in Islet Transplantation (SIT) Empagliflozin 25 MG Oral Tablet, Empagliflozin 10 MG Oral Tablet [Jardiance] - Partial Islet Function, TPIAT | Phase 4 | Recruiting | University of Minnesota | 40 | 2026-07-21 | 2026-07-22 |
| PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis Rosuvastatin 20 Mg Oral Tablet, Colchicine 0.5 MG Oral Tablet Once Daily, Placebo - Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression | Phase 3 | Recruiting | Duke University | 1500 | 2026-07-21 | 2026-11-10 |
| Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients PCSK9 inhibitor plus rosuvastatin 20 mg tab, Rosuvastatin 20 Mg Oral Tablet - Acute Coronary Syndromes | Phase 3 | Not yet recruiting | Assiut University | 120 | 2026-07-01 | 2026-07-30 |
Showing 20 of 1011. Sign in to see all of them.
Diabetes Mellitus, Type 2 (34) · Pain (21) · Breast Neoplasms (20) · Hypertension (18) · Pain, Postoperative (17) · Acquired Immunodeficiency Syndrome (16) · Cardiovascular Diseases (16) · HIV Infections (16) · Diabetes Mellitus (15) · Obesity (13) · Renal Insufficiency, Chronic (13) · Neoplasms (11) · Polycystic Ovary Syndrome (11) · Acute Coronary Syndrome (10) · Cognitive Dysfunction (10)
GlaxoSmithKline (26) · Ain Shams University (17) · Tanta University (17) · Boehringer Ingelheim (12) · Assiut University (11) · AstraZeneca (10) · Bayer (9) · Mutual Pharmaceutical Company, Inc. (9) · Actavis Inc. (8) · Chong Kun Dang Pharmaceutical (8) · Teva Pharmaceuticals USA (7) · Cairo University (6) · Kafrelsheikh University (6) · Mansoura University (6) · Ranbaxy Laboratories Limited (6)
United States (274) · Egypt (90) · China (69) · Canada (54) · United Kingdom (50) · Germany (39) · South Korea (39) · Italy (31) · France (30) · Spain (28) · Belgium (26) · Netherlands (26) · Australia (25) · Denmark (23) · Mexico (20)
Benoit Girard, M.D. (4) · Abeer Mohamed Elkholy, MD Dermatology (2) · Amr M Elnaghy, PhD (2) · Anthony R Godfrey, Pharm.D. (2) · Antonio R. Pizarro,, M.D. (2) · Bruce T Czarnik, M.D. (2)
PMID 31867054, PMID 42653697, PMID 12807523, PMID 16731270, PMID 18190818, PMID 20432394, PMID 20531008, PMID 20681275, PMID 22019563, PMID 22114906, PMID 22338284, PMID 23303884, PMID 24361112, PMID 25962554, PMID 27480425, PMID 27847338, PMID 28525302, PMID 29490031, PMID 31613965, PMID 31779508, PMID 33586138, PMID 34826668, PMID 35265033, PMID 37989369, PMID 40785326, PMID 10190267, PMID 10347109, PMID 10625102, PMID 10647798, PMID 10650325, PMID 10798549, PMID 10859281, PMID 10870281, PMID 10919968, PMID 11020772, PMID 11163814, PMID 11277825, PMID 11326085, PMID 11383749, PMID 11393894, PMID 11448564, PMID 11519503, PMID 11529691, PMID 11587154, PMID 11705426, PMID 11726570, PMID 11729302, PMID 11756098, PMID 11772973, PMID 11782957
2017 (8), 2023 (8), 2015 (7), 2019 (6), 2018 (5), 2009 (4), 2016 (4), 2014 (2), 2025 (2), R01AR071263 (2), 1UG3DA061620 (1), 2005 (1), 2008 (1), K01DA052673 (1), P20DA024157 (1)